A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers
- PMID: 22263713
- PMCID: PMC3365863
- DOI: 10.1080/08897077.2011.609438
A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers
Abstract
A feasibility study was conducted to pilot test the ability of 5 sites to recruit, treat, and retain opioid-dependent offenders in a trial of extended-release injectable naltrexone (XR-NTX). The participants, 61 previously opioid-dependent individuals under legal supervision in the community, received up to 6 monthly injections of Depotrex brand naltrexone and completed a 6-month follow-up interview. Six-month outcomes showed that those who completed treatment had significantly fewer opioid-positive urines and were less likely to have been incarcerated than those who had not completed treatment. The findings indicate that XR-NTX holds promise as a feasible, effective treatment option for opioid-dependent offenders.
References
-
- Nurco DN, Hanlon TE, Kinlock TW, Duszynski KR. The consistency of types of criminal behavior over preaddiction, addiction, and nonaddiction status periods. Compr Psychiatry Sep-Oct. 1989;30(5):391–402. - PubMed
-
- Inciardi J. War on Drugs IV. 4. Boston: Pearson; 2008.
-
- Kinlock TW, Gordon MS, Schwartz RP. Incarcerated populations. In: Ruiz P, Strain E, editors. Lowinson & Ruiz’s Substance Abuse: A Comprehensive Textbook. 5. Lippincott Williams & Wilkins; In press.
-
- Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York: Springer-Verlag; 1991.
-
- Kleber HD. Methadone maintenance 4 decades later: thousands of lives saved but still controversial. JAMA. 2008 Nov 19;300(19):2303–2305. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
